Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Tempest Therapeutics, Inc. | 231,482 | reported | 24 Mar 2026 | tx 2+501,103 |
| Ernexa Therapeutics Inc. | 132,003 | reported | 12 Jan 2023 | tx 2+2,619,006 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 Mar 2026 | PURCHASE | Tempest Therapeutics, Inc. | 231,482 | 2.16 USD | |
| 04 Feb 2026 | GRANT_AWARD | Tempest Therapeutics, Inc. | 269,621 | 0.00 USD | deriv |
| 12 Jan 2023 | GRANT_AWARD | Ernexa Therapeutics Inc. | 132,003 | 0.00 USD | deriv |
| 01 Aug 2022 | GRANT_AWARD | Ernexa Therapeutics Inc. | 2,487,003 | 0.00 USD | deriv |